- Home
- ASTH
as 09-15-2025 4:00pm EST
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | ALHAMBRA |
| Market Cap: | 1.4B | IPO Year: | N/A |
| Target Price: | $53.29 | AVG Volume (30 days): | 333.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.52 | EPS Growth: | -63.67 |
| 52 Week Low/High: | $21.20 - $63.20 | Next Earning Date: | 11-06-2025 |
| Revenue: | $2,419,115,000 | Revenue Growth: | 51.97% |
| Revenue Growth (this year): | 60.77% | Revenue Growth (next year): | 26.90% |
Latest Astrana Health Inc. Common Stock News
ASTH Breaking Stock News: Dive into ASTH Ticker-Specific Updates for Smart Investing
StockStory
25 days ago
Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
StockStory
3 months ago
5 Must-Read Analyst Questions From Astrana Health’s Q1 Earnings Call
Healthcare Dive
3 months ago
Prospect Medical Systems lays off 125
StockStory
3 months ago
2 Healthcare Stocks with Competitive Advantages and 1 to Keep Off Your Radar
Simply Wall St.
3 months ago
Should You Investigate Astrana Health, Inc. (NASDAQ:ASTH) At US$26.70?
Argus Research
3 months ago
ASTH: Raising target price to $21.00
Argus Research
3 months ago
ASTH: Raising target price to $21.00
Simply Wall St.
3 months ago
3 Growth Companies With High Insider Ownership And Up To 115% Earnings Growth
Compare ASTH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ASTH Astrana Health Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.